PharmaBoardroom

Interview: Florian Ibe – Managing Director, Bayer Portugal

Florian Ibe, managing director at Bayer Portugal, discusses market access hurdles, as well as Portugal’s expertise in scientific and clinical…

Interview: Paulo Climaco Lilaia – President, APOGEN,…

Paulo Lilaia, president of the board of APOGEN and CEO of Generis, highlights the need for generics in the healthcare system and the government’s…

Humberto Arnés – Director General, Farmaindustria, Spain

Humberto Arnés, director general at Farmaindustria, Spain’s leading pharmaceutical industry association, discusses the dynamics of the Spanish…

Interview: Ana Teresa Lehmann – Secretary of State for…

The Portuguese secretary of state for industry invites readers to discover the vibrant tech landscape in Portugal. Ana Teresa Lehmann unravels the…

Interview: Grace Zhou – Dean, Shenzhen International…

Dr. Grace Zhou, dean of SIIBR, discusses the Institute’s priorities, the benefits of being located in Shenzhen and the city’s potential as a…

Interview: Paul Apap Bologna – Managing Director,…

Paul Apap Bologna, managing director at Associated Drug Company (ADC), introduces his family company, focused on distributing high-quality innovative…

Interview: Claude A. Farrugia – Chairman, Pharmaceutical…

Prof. Claude A. Farrugia of the Malta Chamber of Commerce, Enterprise and Industry documents the main trends in the manufacturing industry of Malta…

Interview: Tang Dajie – Founder and CEO, Triwise Capital,…

Dr. Tang Dajie, founder and CEO of investment vehicle Triwise Capital, discusses the numerous investment opportunities in Shenzhen’s life sciences…

Mike Thompson – Chief Executive, ABPI, UK

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (ABPI) reveals his staunch faith in the British health…

Takeda/Shire Deal to Spark Pharma M&A Boom?

With the USD 62 billion deal from Japan’s Takeda Pharmaceutical to buy Irish firm Shire finally agreed after months of wrangling, we asked…

Neil Closner – CEO, MedReleaf, Canada

With already 20 percent of market share in the medical cannabis sector in Canada, MedReleaf is getting ready for the upcoming legalization of cannabis…

Bob McLay – Vice President and General Manager, Sobi Canada

Bob McLay, vice president and general manager of Sobi in Canada, discusses how innovation and collaboration with regulators and payers are helping…

Tagged with r